Compare AGCO Corporation (AGCO) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AGCO Corporation vs Twist Bioscience Corp — how do they compare? AGCO Corporation trades at $102.25 (market cap $7.10B), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: AGCO Corporation and Twist Bioscience Corp are close in size by market cap, and AGCO Corporation pays a 1.18% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| AGCO | TWST | |
|---|---|---|
Market Cap | $7.10B | $7.72B |
Sector | Industrials | Health |
52-Week High | $140.49 | $124.88 |
52-Week Low | $100.14 | $24.16 |
Enterprise Value | $9.37B | $7.65B |
Dividend Yield | 1.18% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AGCO Corporation
Agco is a global manufacturer of agricultural equipment. The company has five principal brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements by offering grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes over 3,200 dealer and distribution locations. Additionally, Agco offers both retail and wholesale financing to customers through its joint venture with Rabobank, a European food and agriculture focused bank.
Read more on AGCO →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
